NDC11 55154142508
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55154-1425-08 | 55154-1425 |
| 55154-1425-8 | 55154-1425 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INVOKANA | CANAGLIFLOZIN | Cardinal Health 107, LLC | 5f76e16f-0c24-454a-81af-4080b312c940 | 2026-02-17 | Warnings, Adverse reactions | 55154-1425-8 55154-1425 55154142508 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.